Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked
There is limited understanding of the dysregulation of the innate immune system in multiple myeloma (MM). We analysed the expression of the activating receptor NKG2D on NK cells and T cells of MM patients and investigated the impact of soluble versus membrane-bound NKG2D ligands on the expression of...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2010
|
| In: |
Cancer immunology immunotherapy
Year: 2010, Volume: 59, Issue: 6, Pages: 829-839 |
| ISSN: | 1432-0851 |
| DOI: | 10.1007/s00262-009-0807-3 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00262-009-0807-3 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s00262-009-0807-3 |
| Author Notes: | Marie von Lilienfeld-Toal, Susanne Frank, Christiane Leyendecker, Sylvia Feyler, Sarah Jarmin, Ruth Morgan, Axel Glasmacher, Angela Märten, Ingo G.H. Schmidt-Wolf, Peter Brossart, Gordon Cook |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1859545025 | ||
| 003 | DE-627 | ||
| 005 | 20240311124057.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230914s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00262-009-0807-3 |2 doi | |
| 035 | |a (DE-627)1859545025 | ||
| 035 | |a (DE-599)KXP1859545025 | ||
| 035 | |a (OCoLC)1425873878 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lilienfeld-Toal, Marie von |d 1971- |e VerfasserIn |0 (DE-588)121251268 |0 (DE-627)081183585 |0 (DE-576)29260937X |4 aut | |
| 245 | 1 | 0 | |a Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked |c Marie von Lilienfeld-Toal, Susanne Frank, Christiane Leyendecker, Sylvia Feyler, Sarah Jarmin, Ruth Morgan, Axel Glasmacher, Angela Märten, Ingo G.H. Schmidt-Wolf, Peter Brossart, Gordon Cook |
| 264 | 1 | |c 2010 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht am 19. Dezember 2009 | ||
| 500 | |a Gesehen am 14.09.2023 | ||
| 520 | |a There is limited understanding of the dysregulation of the innate immune system in multiple myeloma (MM). We analysed the expression of the activating receptor NKG2D on NK cells and T cells of MM patients and investigated the impact of soluble versus membrane-bound NKG2D ligands on the expression of NKG2D. | ||
| 650 | 4 | |a Immune escape | |
| 650 | 4 | |a Innate immunity | |
| 650 | 4 | |a MGUS | |
| 650 | 4 | |a MICA | |
| 650 | 4 | |a Multiple myeloma | |
| 650 | 4 | |a NKG2D | |
| 700 | 1 | |a Frank, Susanne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Leyendecker, Christiane |e VerfasserIn |4 aut | |
| 700 | 1 | |a Feyler, Sylvia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jarmin, Sarah |e VerfasserIn |4 aut | |
| 700 | 1 | |a Morgan, Ruth |e VerfasserIn |4 aut | |
| 700 | 1 | |a Glasmacher, Axel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Märten, Angela |d 1968- |e VerfasserIn |0 (DE-588)122240103 |0 (DE-627)081822456 |0 (DE-576)293167931 |4 aut | |
| 700 | 1 | |a Schmidt-Wolf, Ingo G. H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brossart, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Cook, Gordon |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer immunology immunotherapy |d Berlin : Springer, 1976 |g 59(2010), 6, Seite 829-839 |h Online-Ressource |w (DE-627)253390443 |w (DE-600)1458489-X |w (DE-576)072283475 |x 1432-0851 |7 nnas |a Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked |
| 773 | 1 | 8 | |g volume:59 |g year:2010 |g number:6 |g pages:829-839 |g extent:11 |a Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00262-009-0807-3 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00262-009-0807-3 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230914 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 122240103 |a Märten, Angela |m 122240103:Märten, Angela | ||
| 999 | |a KXP-PPN1859545025 |e 437593851X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Marie von","family":"Lilienfeld-Toal","role":"aut","roleDisplay":"VerfasserIn","display":"Lilienfeld-Toal, Marie von"},{"roleDisplay":"VerfasserIn","display":"Frank, Susanne","role":"aut","family":"Frank","given":"Susanne"},{"family":"Leyendecker","given":"Christiane","roleDisplay":"VerfasserIn","display":"Leyendecker, Christiane","role":"aut"},{"family":"Feyler","given":"Sylvia","display":"Feyler, Sylvia","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Jarmin, Sarah","roleDisplay":"VerfasserIn","role":"aut","family":"Jarmin","given":"Sarah"},{"roleDisplay":"VerfasserIn","display":"Morgan, Ruth","role":"aut","family":"Morgan","given":"Ruth"},{"given":"Axel","family":"Glasmacher","role":"aut","display":"Glasmacher, Axel","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Märten, Angela","role":"aut","family":"Märten","given":"Angela"},{"display":"Schmidt-Wolf, Ingo G. H.","roleDisplay":"VerfasserIn","role":"aut","family":"Schmidt-Wolf","given":"Ingo G. H."},{"family":"Brossart","given":"Peter","roleDisplay":"VerfasserIn","display":"Brossart, Peter","role":"aut"},{"family":"Cook","given":"Gordon","roleDisplay":"VerfasserIn","display":"Cook, Gordon","role":"aut"}],"title":[{"title_sort":"Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked","title":"Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked"}],"language":["eng"],"recId":"1859545025","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online veröffentlicht am 19. Dezember 2009","Gesehen am 14.09.2023"],"name":{"displayForm":["Marie von Lilienfeld-Toal, Susanne Frank, Christiane Leyendecker, Sylvia Feyler, Sarah Jarmin, Ruth Morgan, Axel Glasmacher, Angela Märten, Ingo G.H. Schmidt-Wolf, Peter Brossart, Gordon Cook"]},"id":{"eki":["1859545025"],"doi":["10.1007/s00262-009-0807-3"]},"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"2010"}],"relHost":[{"part":{"text":"59(2010), 6, Seite 829-839","volume":"59","extent":"11","year":"2010","issue":"6","pages":"829-839"},"titleAlt":[{"title":"CII"}],"pubHistory":["1.1976 -"],"recId":"253390443","language":["eng"],"disp":"Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linkedCancer immunology immunotherapy","note":["Gesehen am 15.05.2024","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 52.2003: Supplement"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"subtitle":"CII","title":"Cancer immunology immunotherapy","title_sort":"Cancer immunology immunotherapy"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1432-0851"],"zdb":["1458489-X"],"eki":["253390443"]},"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"1976-","dateIssuedKey":"1976","publisher":"Springer"}]}],"physDesc":[{"extent":"11 S."}]} | ||
| SRT | |a LILIENFELDREDUCEDIMM2010 | ||